Skip to content
Screener

Doximity DOCS Stock-Based Comp

Stock-Based Comp at other companies

Microsoft logo
MicrosoftMSFT
$3.12B+1.6%
Ziff Davis logo
Ziff DavisZD
$12.98M+10.7%
AMN Healthcare logo
AMN HealthcareAMN
$9.84M+11.5%
Veeva Systems logo
Veeva SystemsVEEV
$119.26M+6.3%
OptimizeRx logo
OptimizeRxOPRX
$1.83M+17.3%
Teladoc Health logo
Teladoc HealthTDOC
$9.3M-58.4%

Other financials

Income statement

See full
Revenue$156.6M+7.3%
Gross profit$132.9M+2.2%
Operating income$33.6M-38.3%
Net income$24.3M-54.4%
EPS (diluted)$0.13-51.9%

Balance sheet

See full
Cash & equivalents$273.6M+99.3%
Total debt$9.7M-18.3%
Total equity$916.1M-10.7%
Total assets$1.1B-10.0%

Cash flow

See full
Operating cash flow$42.0M-32.4%
CapEx$62.0K
Free cash flow$41.9M-32.5%

Valuation

See full
Market cap$3.77B-65.4%
Enterprise value$3.5B-67.5%
P/E22.6×-23.8×
P/S5.8×-12.7×

Profitability

See full
Gross margin88.1%-2.1pp
Operating margin29.6%-10.5pp
Net margin25.5%-14.4pp
FCF margin49.9%+15.8pp

Returns & leverage

See full
Return on equity17.2%-7.0pp
Debt / equity0.0×
Current ratio6.1×-0.4×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Doximity’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:12 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001516513-26-000040
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025
Net income$24,315$53,320
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization4,2872,794
Stock-based compensation, net of amounts capitalized36,75221,865
Non-cash lease expense387450
Accretion of discount on marketable securities, net(568)(2,488)
Amortization of deferred contract costs4,3003,896
Other(338)(408)

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Doximity's stock-based comp?
Doximity (DOCS) reported stock-based comp of $36.75M in Q2 2026.
How has Doximity's stock-based comp changed year-over-year?
Doximity's stock-based comp increased by 68.1% year-over-year, from $21.87M to $36.75M.
What is the long-term trend for Doximity's stock-based comp?
Over 4 years (2022 to 2026), Doximity's stock-based comp has grown at a 40.2% compound annual growth rate (CAGR), from $31.44M to $121.63M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about Doximity's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude